Company Search:
Advanced Search
Sponsored Links
Orexo AB - ADR Company Snapshot
Orexo AB - ADR operates within the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Orexo AB - ADR with three other companies in this sector in the United States: Lexicon Pharmaceuticals Incorporated (2016 sales of $83.34 million of which 100% was Pharmaceutical R&D), Corcept Therapeutics Incorporated ($81.32 million of which 100% was Pharmaceutical Products), and Ptc Therapeutics Inc ($82.71 million of which 100% was Bio Pharmaceutical).

Sales Analysis. During the year ended December of 2016, sales at Orexo AB - ADR were $82.29 million. This is an increase of 8.2% versus 2015, when the company's sales were $76.03 million. Despite this increase, sales are still slightly below the level achieved in 2014, when Orexo AB - ADR reported sales of $82.71 million. Sales of Zubsolv saw an increase of 14.1% in 2016, from $49.25 million to $56.17 million. Not all segments of Orexo AB - ADR experienced an increase in sales in 2016: sales of Milestone Payment Abstral fell 96.7% to $256,476.00 . Orexo AB - ADR also experienced decreases in sales in Royalty - Abstral (down 26.2% to $11.70 million) .
  Stock Performance Chart for Orexo AB - ADR
  Stock Data: Recent Stock Performance:
  Current Price (12/11/2017): 4.42
(Figures in U.S. Dollars)
1 Week n/a   13 Weeks n/a  
4 Weeks n/a   52 Weeks n/a  
Orexo AB - ADR Key Data:
  Ticker: ORXOY Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 82,293,822
(Year Ending Jan 2017).
Employees: 102
  Currency: U.S. Dollars Market Cap: 152,664,966
  Fiscal Yr Ends: December Shares Outstanding: 34,539,585
  Share Type: Common Closely Held Shares: 4,337,469
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.